Inactivation of hippo pathway is significantly associated with poor prognosis in hepatocellular carcinoma

Clinical Cancer Research

Volumn 22, Issue 5, 2016, Pages 1256-1264

  Sohn, Bo Hwa ^a   Shim, Jae Jun ^a,b   Kim, Sang Bae ^a   Jang, Kyu Yun ^c   Kim, Soo Mi ^c   Kim, Ji Hoon ^d   Hwang, Jun Eul ^a   Jang, Hee Jin ^a   Lee, Hyun Sung ^a   Kim, Sang Cheol ^e   Jeong, Woojin ^f   Kim, Sung Soo ^b   Park, Eun Sung ^g   Heo, Jeonghoon ^h   Kim, Yoon Jun ^c   Kim, Dae Ghon ⁱ   Leem, Sun Hee ^j   Kaseb, Ahmed ^a   Hassan, Manal M ^a   Cha, Minse ^a   Chu, In Sun ^k   Johnson, Randy L ^a   Park, Yun Yong ^l   Lee, Ju Seog ^a,b   more..

^a UNIVERSITY OF TEXAS   (United States)

^b Kyung Hee University Hospital   (South Korea)

^c Chonbuk National University Medical School   (South Korea)

^d Korea University College of Medicine   (South Korea)

^e Korea National Institute of Health   (South Korea)

^f Ewha Womans University   (South Korea)

^g Inha University School of Medicine   (South Korea)

^h Kosin University College of Medicine   (South Korea)

ⁱ Seoul National University College of Medicine   (South Korea)

^j Dong A University   (South Korea)

^k Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^l University of Ulsan College of Medicine   (South Korea)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER STEM CELL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENE INACTIVATION; GENOMICS; HIPPO GENE; HUMAN; HUMAN TISSUE; KOREAN (PEOPLE); LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MOUSE; NONHUMAN; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; TUMOR SUPPRESSOR GENE; VALIDATION STUDY; VERY ELDERLY; ANIMAL; BIOSYNTHESIS; DISEASE FREE SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; LIVER TUMOR; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

HIPPO PROTEIN, HUMAN; PHOSPHOPROTEIN; PROTEIN SERINE THREONINE KINASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TAZ PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER; YAP1 (YES-ASSOCIATED) PROTEIN, HUMAN;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MICE; MIDDLE AGED; PHOSPHOPROTEINS; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84962233261     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-15-1447     Document Type: Article

References (37)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108.
2. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El Serag HB. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 2004;127:1372-80.
3. El Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-50.
4. El Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004;127:S27-S34.
5. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
6. Halder G, Johnson RL. Hippo signaling: growth control and beyond. Development 2011;138:9-22.
7. Pan D. Hippo signaling in organ size control. Genes Dev 2007;21:886-97.
8. Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007;130:1120-33.
9. Saucedo LJ, Edgar BA. Filling out theHippo pathway. Nat RevMol Cell Biol 2007;8:613-21.
10. Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch R, et al. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 2007;17:2054-60.
11. Lu L, Li Y, Kim SM, Bossuyt W, Liu P, Qiu Q, et al. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci U S A 2010;107:1437-42.
12. Lee KP, Lee JH, Kim TS, Kim TH, Park HD, Byun JS, et al. The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc Natl Acad Sci U S A 2010;107:8248-53.
13. Song H, Mak KK, Topol L, Yun K, Hu J, Garrett L, et al. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci U S A 2010;107:1431-6.
14. Zhou D, Conrad C, Xia F, Park JS, Payer B, Yin Y, et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 2009;1916:425-38.
15. Boyault S, Rickman DS, de RA, Balabaud C, Rebouissou S, Jeannot E, et al. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 2007;45:42-52.
16. Chiang DY, Villanueva A, Hoshida Y, Peix J, Newell P, Minguez B, et al. Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res 2008;68:6779-88.
17. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A, et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 2008;359:1995-2004.
18. Lee JS, Chu IS, Heo J, Calvisi DF, Sun Z, Roskams T, et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 2004;40:667-76.
19. Lee JS, Chu IS, Mikaelyan A, Calvisi DF, Heo J, Reddy JK, et al. Application of comparative functional genomics to identify best-fit mouse models to study human cancer. Nat Genet 2004;36:1306-11.
20. Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, Calvisi DF, et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med 2006;12:410-6.
21. Woo HG, Park ES, Cheon JH, Kim JH, Lee JS, Park BJ, et al. Gene expressionbased recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma. Clin Cancer Res 2008;14:2056-64.
22. Roessler S, Jia HL, Budhu A, Forgues M, Ye QH, Lee JS, et al. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res 2010;70:10202-12.
23. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003;19:185-93.
24. Simon R, Lam A, Li M-C, Ngan M, Menenzes S, Zhao Y. Analysis of gene expression data using BRB-Array Tools. Cancer Inform 2007;3:11-7.
25. Wright GW, Simon RM. A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 2003;19:2448-55.
26. Cox DR. Regression models with life tables. J Royal Statis Soc 1972;34: 187-220.
27. KattanMW.Evaluating a newmarker's predictive contribution. Clin Cancer Res 2004;10:822-4.
28. Kattan MW. Judging new markers by their ability to improve predictive accuracy. J Natl Cancer Inst 2003;95:634-5.
29. Lee JS, Leem SH, Lee SY, Kim SC, Park ES, Kim SB, et al. Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors. J Clin Oncol 2010;28:2660-7.
30. Radmacher MD, McShane LM, Simon R. A paradigm for class prediction using gene expression profiles. J Comput Biol 2002;9:505-11.
31. Oh SC, Park YY, Park ES, Lim JY, Kim SM, Kim SB, et al. Prognostic gene expression signature associated with two molecularly distinct subtypes of colorectal cancer. Gut 2012;61:1291-8.
32. Park YY, Kim K, Kim SB, Hennessy BT, Kim SM, Park ES, et al. Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer. EMBO Mol Med 2012;4:52-67.
33. Zhao B, Ye X, Yu J, Li L, Li W, Li S, et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 2008;22:1962-71.
34. Kim SM, Leem SH, Chu IS, Park YY, Kim SC, Kim SB, et al. 65-gene-based risk score classifier predicts overall survival in hepatocellular carcinoma. Hepatology 2012;55:1443-52.
35. Zoncu R, Efeyan A, SabatiniDM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011;12:21-35.
36. Tumaneng K, Schlegelmilch K, Russell RC, Yimlamai D, Basnet H, Mahadevan N, et al. YAP mediates crosstalk between the Hippo and PI(3)K-TOR pathways by suppressing PTEN via miR-29. Nat Cell Biol 2012;14:1322-9.
37. Sims AH, Howell A, Howell SJ, Clarke RB.Origins of breast cancer subtypes and therapeutic implications. Nat Clin Pract Oncol 2007;4:516-25.